A study has found no evidence that glucagon-like peptide 1 receptor agonist (GLP1-RA) use is associated with an increased risk of thyroid cancer. The study is published in the peer-reviewed ...

Eli Lilly (LLY) stock fell as its obesity therapy tirzepatide missed forecasts, amid focus on compounded weight loss ...

The report from AARP Public Policy Institute said average list prices on these 25 drugs have nearly doubled since they hit the market and collectively cost Medicare ‒ and American taxpayers ...

One in eight people living in the United States has taken a GLP-1 medication — such as Ozempic, Mounjaro, or Zepbound — for ...

McDonald's shares underperformed in 2024, likely due to the rise of GLP-1 medications. Learn why MCD stock is a Sell.

For the first time in over a decade, obesity rates have dropped in the United States. A recent study by the CDC showed that ...

Eli Lilly's popular obesity drug Zepbound can now be covered by government-backed Medicare drug plans, CNBC reported on ...

But lately, she's been having panic attacks because she fears running out of medication. Citing a gross cost of $1.4 million a month, West Virginia abruptly announced in March it would ...

The UK's first safer drugs consumption room is officially open. The Thistle - based in Glasgow's east end - will allow users to be able to consume drugs, including injecting heroin, under ...

How about I drink some beers? ’” he told Mr. Cain. “And one beer leads to many, leads to self-medication, leads to ‘I’ve earned this.’ Like, ‘Don’t tell me I can’t.’” ...

Most of the 35,000 online pharmacies around the world are operating illegally and could be selling dangerous or ineffective drugs, according to the U.S. Trade Representative's annual "notorious ...